Dr. Dube is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1000
Los Angeles, CA 90033Phone+1 323-442-5100Fax+1 323-467-7119
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Infectious Disease, 1990 - 1992- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1983 - 1986
Boston University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1985 - 2025
IN State Medical License 2000 - 2009- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients Start of enrollment: 1999 Apr 01
- Effects of Storage on Lactate in Blood Samples Start of enrollment: 2001 Jan 01
- Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsA Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency ...Michael P. Dubé, Ellen S. Chan, Jordan E. Lake, Brett Williams, Jennifer Kinslow
Clinical Infectious Diseases. 2019-09-13 - 38 citationsChanges in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260sSahera Dirajlal-Fargo, Carlee Moser, Todd T. Brown, Theodoros Kelesidis, Michael P. Dubé
Open Forum Infectious Diseases. 2016-05-01 - 9 citationsGenital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapySara Gianella, Christine C. Ginocchio, Eric S. Daar, Michael P. Dubé, Sheldon R. Morris
BMC Infectious Diseases. 2015-12-01
Journal Articles
- Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex with MenJill Blumenthal, David J Moore, Michael P Dube, Sheldon R Morris, The Journal of Infectious Diseases
Press Mentions
Keck Medicine of USC Enrolling Volunteers to Test COVID-19 DrugNovember 19th, 2020- USC Seeking Vernon Factory Workers to Volunteer for COVID-19 Vaccine TrialAugust 17th, 2020
Keck Medicine to Launch Clinical Trial for Coronavirus TreatmentMay 7th, 2020
Grant Support
- Switch To Atazanavir And Brachial Artery Reactivity (SABAR) Study: EndotheliaNational Center For Research Resources2007–2008
- Cross-Sectional And Longitudinal Study Of Endothelial Function By Brachial Flow-National Center For Research Resources2007–2008
- A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources2007–2008
- A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources2007–2008
- Pilot Study To Establish The Use Of Brachial Ultrasound To Measure Vascular RNational Center For Research Resources2006–2008
- PLAN For Obtaining Informed Consent To Use Stored Human Biological MaterialsNational Center For Research Resources2004–2008
- Effect Of HIV-1 Protease Inhibitors On Endothelial Function And GlucoseNational Center For Research Resources2004–2008
- A Phase IIIB, Open-Label, Randomized, Multi-Center Study Comparing The AntiviNational Center For Research Resources2006
- Immuno &Viro Indices To Study The HIV Disease Progression Assoc W/AgingNational Center For Research Resources2005–2006
- A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, ParaNational Center For Research Resources2005–2006
- A Phase II Trial Of The Effect Of Combination Therapy With Fish Oil SupplemenNational Center For Research Resources2005–2006
- Trial Of Physiologic Testosterone Supplementation For Hiv-Positive(A5079)National Center For Research Resources2004–2006
- Effect Of A Protease Inhibitor-Containing Or A Non-Protease Inhibitor-ContainingNational Center For Research Resources2004–2006
- Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTSNational Center For Research Resources2005
- Thymidine Analogue Substitution Or Change To A Nucleoside-Sparing RegimenNational Center For Research Resources2004–2005
- Extended-Release Niacin For The Treatment Of Elevated Non-Hdl CholesterolNational Center For Research Resources2004–2005
- Alendronate In Hiv-Infected Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2004–2005
- Endothelial Dysfunction Due To HIV-1 Protease InhibitorsNational Heart, Lung, And Blood Institute2002–2005
- Temporary Cessation Of ART &Resistance Testing In Response To Salvage TherapyNational Center For Research Resources2004
- Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTS.National Center For Research Resources2004
- Immuno &Viro Indices To Study The HIV Disease Progression Assoc. W/AgingNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
